Runyi Ye
58# Zhongshan Two Road
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Clinical Impact of Obesity on Postoperative Outcomes of Patients With Thyroid Cancer Undergoing Thyroidectomy: A 5-Year Retrospective Analysis From the US National Inpatient Sample.
Journal: Cancer medicine
Published: October 10, 2023
KIF17 maintains the epithelial phenotype of breast cancer cells and curbs tumour metastasis.
Journal: Cancer letters
Published: May 22, 2022
Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple-negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta.
Journal: Clinical and translational medicine
Published: September 28, 2021
LncRNA LGALS8-AS1 Promotes Breast Cancer Metastasis Through miR-125b-5p/SOX12 Feedback Regulatory Network.
Journal: Frontiers in oncology
Published: May 19, 2021
AHNAK2 promotes thyroid carcinoma progression by activating the NF-κB pathway.
Journal: Life sciences
Published: November 25, 2020
Correction to: IGFBP7 inhibits cell proliferation by suppressing AKT activity and cell cycle progression in thyroid carcinoma.
Journal: Cell & bioscience
Published: June 07, 2019
Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.
Journal: Cancer management and research
Published: March 14, 2019
Long Noncoding RNA LOC100129940-N Is Upregulated in Papillary Thyroid Cancer and Promotes the Invasion and Progression.
Journal: International journal of endocrinology
Published: November 05, 2018
Prospect for Application of PARP Inhibitor in Patients with HER2 Negative Breast Cancer.
Journal: International journal of biological sciences
Published: October 16, 2018
Last Updated: 09/26/2026